Todas as fotos(1)



Parathyroid Hormone Fragment 1-34 human

≥95% (HPLC), powder

PTH 1-34, Teriparatide, Parathormone (1-34)
Empirical Formula (Hill Notation):
Número CAS:
Peso molecular:
Número MDL:

Nível de qualidade



≥95% (HPLC)



nº de adesão UniProt

temperatura de armazenamento




InChI key


Gene Information

human ... PTH(5741)

Procurando produtos similares? Visit Guia de comparação de produtos

Amino Acid Sequence


Ações bioquímicas/fisiológicas

Parathyroid hormone (PTH) is a parathyroid-secreted polypeptide hormone that increases the level of calcium in blood by enhancing calcium mobilization from bone, increasing the calcium:phosphate ratio in the kidney and promoting the absorption of calcium by the intestines. PTH is an anabolic agent that improves osteoblastic bone development. PTH 1-34 induces bone morphogenetic protein (BMP) gene transcription. Active N-terminal fragment of PTH (residues 1–34), has been used as a therapeutic for postmenopausal women with osteoporosis who are at high risk for fracture.

Outras notas

Lyophilized from 0.1% TFA in H2O

Código de classe de armazenamento

13 - Non Combustible Solids



Ponto de fulgor (ºF)

Not applicable

Ponto de fulgor (ºC)

Not applicable

Equipamento de proteção individual

Eyeshields, Gloves, type N95 (US)

Certificado de análise

Insira o número de lote para pesquisar o Certificado de análise (COA).

Certificado de origem

Insira o número de lote para pesquisar o Certificado de origem (COO).

Pouneh K Fazeli et al.
The Journal of clinical endocrinology and metabolism, 99(4), 1322-1329 (2014-01-25)
Anorexia nervosa (AN), a prevalent psychiatric disorder predominantly affecting women, is characterized by self-induced starvation and low body weight. Increased clinical fractures are common, and most women have low bone mineral density (BMD). Previously investigated treatments have led to no
Adi Cohen et al.
The Journal of clinical endocrinology and metabolism, 98(5), 1971-1981 (2013-04-02)
Premenopausal women with idiopathic osteoporosis (IOP) have abnormal cortical and trabecular bone microarchitecture. The purpose of this study was to test the hypotheses that teriparatide increases bone mineral density (BMD) and bone formation and improves trabecular microarchitecture and stiffness in
Diane Gesty-Palmer et al.
Molecular endocrinology (Baltimore, Md.), 27(2), 296-314 (2013-01-15)
Biased G protein-coupled receptor agonists are orthosteric ligands that possess pathway-selective efficacy, activating or inhibiting only a subset of the signaling repertoire of their cognate receptors. In vitro, D-Trp(12),Tyr(34)-bPTH(7-34) [bPTH(7-34)], a biased agonist for the type 1 PTH receptor, antagonizes
Yumiko Ohbayashi et al.
Oral surgery, oral medicine, oral pathology and oral radiology, 115(4), e31-e37 (2012-12-19)
The management of bisphosphonate-related osteonecrosis of the jaw (BRONJ) is still difficult in many cases that do not respond to conservative treatments. We report a case of BRONJ treated by adjunctive teriparatide therapy for 6 months with monitoring of bone
M Shiraki et al.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 24(1), 219-226 (2012-10-25)
This study investigated the effects of a single administration of teriparatide on bone turnover markers in postmenopausal women. Teriparatide caused a transient increase in bone resorption and inhibition of bone formation followed by a subsequent increase in bone formation and

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica